...
首页> 外文期刊>Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography >Transcatheter Tricuspid Valve-in-Valve Intervention for Degenerative Bioprosthetic Tricuspid Valve Disease
【24h】

Transcatheter Tricuspid Valve-in-Valve Intervention for Degenerative Bioprosthetic Tricuspid Valve Disease

机译:经截管三尖瓣阀内阀门介入退行性生物假杆菌瓣膜病

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Isolated reoperative tricuspid valve replacement is one of the highest risk operations classified in the Society of Thoracic Surgeons registry, particularly in the setting of preexisting right ventricular dysfunction. Transcatheter tricuspid valve-in-valve implantation represents an attractive alternative to redo surgery in patients with tricuspid bioprosthetic valve degeneration who are considered high-risk or unsuitable surgical candidates. In this review article, the authors discuss the emergence of transcatheter tricuspid valve-in-valve therapy, pre-procedural echocardiographic assessment of tricuspid bioprosthetic valve dysfunction, periprocedural imaging required for tricuspid valve-in-valve implantation, and postprocedural assessment of tricuspid transcatheter device function.
机译:孤立的重复特三尖瓣置换是在胸外科医生注册表中分类的最高风险运营之一,特别是在预先存在的右心室功能障碍中。 经截面Tricuspid阀内植入代表了三尖瓣生物植物瓣膜变性患者的有吸引力的选择,患者被认为是高风险或不合适的外科候选者。 在本综述文章中,作者讨论了经转截管三尖瓣阀静脉疗法的出现,三尖瓣生物抑制阀功能障碍的程序前超声心动图评估,三尖瓣内植入所需的百分比成像,以及Tricuspid经丝管装置的后期评估 功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号